| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | - | 4.852 | 227.335 |
| Total Income - EUR | - | - | - | - | - | - | - | - | 5.661 | 227.448 |
| Total Expenses - EUR | - | - | - | - | - | - | - | - | 319 | 178.500 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | - | 5.341 | 48.948 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | - | 4.505 | 39.835 |
| Employees | - | - | - | - | - | - | - | - | 0 | 1 |
Check the financial reports for the company - Oncolife S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | - | 421 | 2.089 |
| Current Assets | - | - | - | - | - | - | - | - | 6.310 | 90.792 |
| Inventories | - | - | - | - | - | - | - | - | 0 | 849 |
| Receivables | - | - | - | - | - | - | - | - | 4.852 | 85.133 |
| Cash | - | - | - | - | - | - | - | - | 1.458 | 4.810 |
| Shareholders Funds | - | - | - | - | - | - | - | - | 4.545 | 44.355 |
| Social Capital | - | - | - | - | - | - | - | - | 40 | 40 |
| Debts | - | - | - | - | - | - | - | - | 2.186 | 48.526 |
| Income in Advance | - | - | - | - | - | - | - | - | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Oncolife S.r.l.